The novel approach of the medication represents a exciting advance in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets multiple pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide114313.blogthisbiz.com/49786634/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment